Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Rotavirus Infections - Overview
Rotavirus Infections - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Rotavirus Infections - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Rotavirus Infections - Companies Involved in Therapeutics Development
Aridis Pharmaceuticals Inc
Beijing Minhai Biotechnology Co Ltd
Bharat Biotech Ltd
Chongqing Zhifei Biological Products Co Ltd
GlaxoSmithKline Plc
Hilleman Laboratories Pvt Ltd
IGY Immune Technologies & Life Sciences Inc
Medicago Inc
Micron Biomedical Inc
Serum Institute of India Ltd
UMN Pharma Inc
Wuhan Healthgen Biotechnology Corp
Yisheng Biopharma Co Ltd
Rotavirus Infections - Drug Profiles
(diphtheria + Haemophilus influenza [serotype B] + hepatitis B + pertussis (acellular,adsorbed) + rotavirus + tetanus) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(rotavirus (virus like particle) + typhiod) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
HY-1002 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
IGY-106 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
poliomyelitis vaccine + rotavirus vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Rotavac-5C - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
rotavirus (pentavalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
rotavirus (virus like particle) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
rotavirus [Serotype P2-VP8] (monovalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
rotavirus [Serotype P2] (trivalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
rotavirus [serotypes G1, G2, G3, G4, G9] (pentavalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
rotavirus [serotypes G1, G2, G3, G4, G9] (pentavalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
rotavirus [serotypes G1, G2, G3, G4, G9] (pentavalent) vaccine 1 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
rotavirus [serotypes G1, G2, G3, G4, P1(8)] (pentavalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
rotavirus vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
rotavirus vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
rotavirus vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
RV-3BB - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
RV-625 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
UMN-103 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Rotavirus Infections - Dormant Projects
Rotavirus Infections - Product Development Milestones
Featured News & Press Releases
Jun 03, 2019: Rotavirus vaccine (Rotarix): patient group direction (PGD) template
Jan 24, 2018: India-made rotavirus vaccine achieves World Health Organization prequalification
Sep 21, 2016: Batavia Biosciences receives grant to develop new vaccine against rotavirus
Jun 20, 2013: Medicago Successfully Produces Plant-based Rotavirus VLP Vaccine Candidate
Nov 10, 2012: GSK’s Rotarix Vaccine To Help Protect Babies Against Rotavirus
Apr 26, 2012: GSK’s Rotarix To Be Introduced In Gha
Nov 21, 2011: GSK And Daiichi Sankyo To Launch Rotarix Oral Liquid Formulation To Prevent Rotavirus Gastroenteritis In Japan
May 19, 2010: Health Sciences Authority Provides Update On Review Of Presence Of Porcine Circovirus In GSK’s Rotarix
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Rotavirus Infections, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Number of Products by Targets, H2 2020
Number of Products by Stage and Targets, H2 2020
Number of Products by Mechanism of Actions, H2 2020
Number of Products by Stage and Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020


List of Tables


Number of Products under Development for Rotavirus Infections, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Rotavirus Infections - Pipeline by Aridis Pharmaceuticals Inc, H2 2020
Rotavirus Infections - Pipeline by Beijing Minhai Biotechnology Co Ltd, H2 2020
Rotavirus Infections - Pipeline by Bharat Biotech Ltd, H2 2020
Rotavirus Infections - Pipeline by Chongqing Zhifei Biological Products Co Ltd, H2 2020
Rotavirus Infections - Pipeline by GlaxoSmithKline Plc, H2 2020
Rotavirus Infections - Pipeline by Hilleman Laboratories Pvt Ltd, H2 2020
Rotavirus Infections - Pipeline by IGY Immune Technologies & Life Sciences Inc, H2 2020
Rotavirus Infections - Pipeline by Medicago Inc, H2 2020
Rotavirus Infections - Pipeline by Micron Biomedical Inc, H2 2020
Rotavirus Infections - Pipeline by Serum Institute of India Ltd, H2 2020
Rotavirus Infections - Pipeline by UMN Pharma Inc, H2 2020
Rotavirus Infections - Pipeline by Wuhan Healthgen Biotechnology Corp, H2 2020
Rotavirus Infections - Pipeline by Yisheng Biopharma Co Ltd, H2 2020
Rotavirus Infections - Dormant Projects, H2 2020